XK Gene McLeod Syndrome with or without Chronic Granulomatous Disease Genetic Test
At DNA Labs UAE, we offer a comprehensive genetic test for XK Gene McLeod syndrome with or without chronic granulomatous disease. This test can provide valuable information about the specific genetic cause of the disorder and help in diagnosis, genetic counseling, and family planning.
Test Details
XK Gene McLeod syndrome is a rare genetic disorder characterized by weak expression of the Kell blood group antigens on red blood cells. It is caused by mutations in the XK gene, which is responsible for producing a protein that helps transport certain molecules across cell membranes. Chronic granulomatous disease (CGD) is another rare genetic disorder that affects the immune system. It is caused by mutations in genes involved in the production of reactive oxygen species (ROS), leading to impaired immune responses and recurrent infections.
Our genetic test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes. By sequencing the DNA obtained from a blood sample, we can identify mutations or variations in the XK gene and genes associated with CGD.
Test Components and Price
The XK Gene McLeod syndrome with or without chronic granulomatous disease genetic test is priced at 4400.0 AED. The test requires a blood sample or extracted DNA, or just one drop of blood on an FTA card.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. The test is performed using NGS technology, which provides accurate and reliable results.
Test Type and Doctor
The test falls under the category of dysmorphology and is conducted by our team of expert pediatricians in the Genetics department.
Pre Test Information
Before undergoing the XK Gene McLeod syndrome with or without chronic granulomatous disease genetic test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the disorder.
Conclusion
NGS genetic testing is a valuable tool in diagnosing XK Gene McLeod syndrome with or without chronic granulomatous disease. It can provide information about the specific mutations present in an individual, aiding in genetic counseling, family planning, and potentially guiding treatment options in the future.
| Test Name | XK Gene McLeod syndrome with or without chronic granulomatous disease Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Dysmorphology |
| Doctor | Pediatrics |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for XK Gene McLeod syndrome with or without chronic granulomatous disease NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with XK Gene McLeod syndrome with or without chronic granulomatous disease NGS Genetic DNA Test gene XK |
| Test Details | XK Gene McLeod syndrome is a rare genetic disorder characterized by weak expression of the Kell blood group antigens on red blood cells. This disorder is caused by mutations in the XK gene, which is responsible for producing a protein that helps transport certain molecules across cell membranes. Chronic granulomatous disease (CGD) is another rare genetic disorder that affects the immune system. It is caused by mutations in genes that encode proteins involved in the production of reactive oxygen species (ROS), which are essential for killing certain types of bacteria and fungi. As a result, individuals with CGD have impaired immune responses, leading to recurrent and severe infections. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify mutations or variations in their sequences. In the context of XK Gene McLeod syndrome with or without CGD, NGS genetic testing can be performed to identify mutations in the XK gene and genes associated with CGD. This genetic test involves obtaining a DNA sample, typically through a blood sample, and subjecting it to NGS analysis. The DNA is sequenced, and the resulting data is compared to a reference genome to identify any genetic variations or mutations. By analyzing the XK gene and CGD-associated genes, the test can provide a diagnosis and determine the specific genetic cause of the disorder. NGS genetic testing can be helpful in confirming a suspected diagnosis of XK Gene McLeod syndrome with or without CGD and can also provide information about the specific mutations present in an individual. This information can be used for genetic counseling, family planning, and potentially guiding treatment options in the future. |
